This paper explores the implications of measurement error in the analysis of compliance}response relationships in data from randomized trials. Given that compliance measures are rarely, if ever, error-free indicators of exposure it is argued that both the designs for the collection of compliance dat
The effect of measuring error on the results of therapeutic trials in advanced cancer
β Scribed by Charles G. Moertel; James A. Hanley
- Publisher
- John Wiley and Sons
- Year
- 1976
- Tongue
- English
- Weight
- 506 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
I n this study, 16 experienced oncologists each measured 12 simulated tumor masses employing their usual clinical methods. Unknown to the oncologists, two pairs of these tumors were identical in size. This permitted a total of 64 measurement comparisons of the same investigator measuring the same size mass and 1920 comparisons of different investigators measuring the same size mass. I f a 50% reduction in the product of perpendicular diameters is accepted as a criterion, the objective response rate due to measuring error alone was 7.8% by the same investigator and 6.8%by different investigators. If a 25% reduction criterion is used, the respective "placebo" response rates were 19% and 25%. I n the clinical setting it is recommended that the 50% reduction criterion be employed and that the investigator should anticipate an objective response rate of 5 to 10% due to human error in tumor measurement.
π SIMILAR VOLUMES
H growth of breast cancer. The pituitary, adrenals, ovaries, and testes have all been implicated. In the female, the oldest historical factor relates to the ovaries. In 1889, Schin-zinger19 suggested that since breast cancer seemed to be worse in younger women, they should be made older by removing
An INFORMATION OFFICE ON CLINICAL THERAPEUTICAL TRIALS in the field of cancer has been established by the Committee on Controlled Therapeutical Trials of the International Union Against Cancer. Those who are planning to start a trial will thus be able to obtain from this Office information on simil
## Abstract This article explores to what extent the poor results that are often found when estimating parameters of production functions can be attributed to measurement errors, due to the use of common price deflators across firms. Because of the lack of detailed microβeconomic data, econometrici
## Abstract Screening for prostate cancer (PC) remains a controversial issue despite some new evidence on the mortality benefits of PC screening. We conducted a prospective, randomized screening trial in Finland to investigate whether screening decreases PC incidence. Here, we report the incidence